1580 Federal Register / Vol. 89, No. 7 / Wednesday, January 10, 2024 / Notices 

on Neurocognitive Development and 

Addiction Risk (TranSINDA). 

Date: February 9, 2024. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Caitlin Elizabeth Angela 

Moyer, Ph.D., Scientific Review Officer, 

Scientific Review Branch, National Institute 

on Drug Abuse, NIH, 301 North Stonestreet 

Avenue, MSC 6021, Bethesda, MD 20892, 

(301) 443–4577, caitlin.moyer@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Chemical Countermeasures Research 

Program Initiative: Research on 

Counteracting the Deleterious Effects of 

Acute Opioid Exposure. 

Date: February 15, 2024. 

Time: 12:30 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Li Rebekah Feng, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Drug Abuse, 

NIH, 301 North Stonestreet Avenue, MSC 

6021, Bethesda, MD 20892, (301) 827–7245, 

rebekah.feng@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Advancing Psychedelics Research for 

Treating Addiction. 

Date: February 21, 2024. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Brian Stefan Wolff, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research, 

National Institute on Drug Abuse, NIH, 301 

North Stonestreet Avenue, MSC 6021, 

Bethesda, MD 20852, (301) 480–1448, 

brian.wolff@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse and Addiction 

Research Programs, National Institutes of 

Health, HHS) 

Dated: January 5, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–00361 Filed 1–9–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–22– 

233: Time-Sensitive Opportunities for Health 

Research. 

Date: January 29, 2024. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Hoa Thi Vo, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1002B2, 

Bethesda, MD 20892, (301) 594–0776, voht@

csr.nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group, Behavioral 

Neuroendocrinology, Neuroimmunology, 

Rhythms, and Sleep Study Section. 

Date: February 1–2, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Michael Selmanoff, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5164, 

MSC 7844 Bethesda, MD 20892, 301–435– 

1119, selmanom@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group, 

Psychosocial Development, Risk and 

Prevention Study Section. 

Date: February 1–2, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Anna L Riley, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

MSC 7759 Bethesda, MD 20892, 301- 435– 

2889, rileyann@csr.nih.gov. 

Name of Committee: Bioengineering 

Sciences & Technologies Integrated Review 

Group; Drug and Biologic Therapeutic 

Delivery Study Section. 

Date: February 1–2, 2024. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications 

Place: National Institutes of Health 

Rockledge II 6701 Rockledge Drive, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Janice Duy, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, 6701 Rockledge Drive, 

Bethesda, MD 20892, 301–594–3139, 

janice.duy@nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group; 

Social Sciences and Population Studies A 

Study Section. 

Date: February 1–2, 2024. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Suzanne Ryan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3139, 

MSC 7770 Bethesda, MD 20892, (301) 435– 

1712, ryansj@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 4, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–00290 Filed 1–9–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 7 / Wednesday, January 10, 2024 / Notices 1581 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Alpha Herpes 

Viruses and Alzheimer’s Disease Progression. 

Date: January 26, 2024. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ivan Tadeu Rebustini, 

Ph.D., Scientific Review Branch, NIA, 7201 

Wisconsin Ave., Rm 100, Bethesda, MD 

20814, (301) 555–1212, ivan.rebustini@

nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: January 4, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–00283 Filed 1–9–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

In compliance with section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 concerning 

opportunity for public comment on 

proposed collections of information, the 

Substance Abuse and Mental Health 

Services Administration (SAMHSA) 

will publish periodic summaries of 

proposed projects. To request more 

information on the proposed projects or 

to obtain a copy of the information 

collection plans, contact the SAMHSA 

Reports Clearance Officer at 

samhsapra@samhsa.hhs.gov. 

Comments are invited on: (a) whether 

the proposed collections of information 

are necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Project: 2023–2026 Advancing Wellness 

and Resilience in Education and 

Trauma Informed Services in Schools 

Cross-Site Evaluation—New Collection 

The Substance Abuse and Mental 

Health Services Administration 

(SAMHSA) Center for Mental Health 

Services (CMHS) is requesting clearance 

for data collection associated with a 

national cross-site evaluation of process, 

outcomes, and impact for the Advancing 

Wellness and Resilience in Education 

(hereinafter referred to as Project 

AWARE) and Trauma-Informed Services 

in Schools (TISS) programs. 

The purpose of the Project AWARE– 

TISS Cross-Site Evaluation is to better 

understand how each program is 

implemented, the extent to which they 

facilitate collaboration between 

education agencies and mental health 

systems, and how each program 

contributes to access and referral to 

mental health services and improved 

outcomes for youth. 

The AWARE–TISS Cross-Site 

Evaluation incorporates four evaluation 

components to provide a robust 

understanding of the implementation 

(process), outcomes, and associated 

impacts of the AWARE and TISS 

Programs and includes program-specific 

components to ensure programmatic 

differences and commonalities are 

understood. With this integrated 

evaluation design, SAMHSA maintains 

the ability to evaluate and report on 

each program separately, while 

additionally benefiting from the ability 

to understand the overarching impact of 

both programs collectively. 

Approval is being requested for data 

collection associated with a Process 

Evaluation and an Outcome Evaluation. 

Several program specific sub-studies 

and cross-program impact analyses will 

also be conducted to assess 

implementation and outcomes overall as 

well as those outcomes specific to highneed subpopulations and underresourced communities. A behavioral 

health equity and cultural equity lens 

will be applied to each area of 

evaluation to ensure a culturally 

specific understanding of intervention 

implementation, outcomes, and 

impacts. 

The Process Evaluation will contain 

two studies (Implementation and 

Sustainability Study and Systems 

Change Study) that examine strategies 

common to both programs related to 

program implementation facilitators and 

barriers, workforce development, and 

grantees’ plans to sustain critical 

program components beyond their grant 

period. This assessment of common 

elements will provide a means to 

compare the implementation strategies 

that are successful across both AWARE 

and TISS grantees and identify 

successes and challenges in changing 

systems, policies, service provision, and 

school climate; increasing behavioral 

health equity in access and service 

delivery; and increasing social and 

emotional development and well-being 

in school-aged children and youth. The 

Process Evaluation will also address 

implementation of program-specific 

components. 

For AWARE, the evaluation will 

document how the grantees implement 

the three-tiered public health model in 

schools and the referral pathways to 

increase access to mental health 

promotion, prevention, and 

intervention. The evaluation will assess 

the grantee collaborative efforts and 

grantee activities intended to increase 

workforce capacity to identify the signs 

and symptoms of mental illness and 

ability to refer to appropriate services 

promptly. 

For TISS, the Process Evaluation will 

focus on examining what innovative 

strategies the grantees use to increase 

access to trauma informed services for 

school-aged youth and how the 

collaborative efforts of grantees and 

their partners develop/improve a 

school-based system for identification, 

referral, early intervention, treatment, 

and supportive services. Additionally, 

the Process Evaluation will assess the 

implementation of training to improve 

school capacity to address trauma 

support needs and engagement of 

families and communities to increase 

awareness of the effects of trauma on 

children and youth. 

The Outcome Evaluation will include 

two studies that examine important 

facets of the AWARE and TISS 

programs: (1) identification and referral 

infrastructure (Identification and 

Referral Study); and (2) youth resiliency 

and outcomes (Youth Resiliency and 

Outcomes Study). Both studies will 

provide critical information about the 

effectiveness of the AWARE and TISS 

programs in establishing and enhancing 

school-based mental health supports for 

students. 

Program specific sub-studies, 

inclusive of two TISS case studies and 

an AWARE Suicide Awareness and 

Prevention Sub-Study, will be 

conducted to provide more extensive 

contextual and implementation 

information related to the AWARE and 

TISS programs. 

Finally, in addition to assessing the 

process and outcomes of each of the 

AWARE and TISS programs, we will 


lotter on DSK11XQN23PROD with NOTICES1